The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose Dense Therapy with Weekly Taxol (T) Plus Carboplatin (C) as First Line Treatment in Advanced Ovarian Cancer (AOC).
 
Furukawa Kenichiro
No Relationships to Disclose
 
Rie Makuuchi
No Relationships to Disclose
 
Keiichi Fujiya
No Relationships to Disclose
 
Noriyuki Nishiwaki
No Relationships to Disclose
 
Hayato Omori
No Relationships to Disclose
 
Sanae Kaji
No Relationships to Disclose
 
Yutaka Tanizawa
No Relationships to Disclose
 
Etsuro Bando
No Relationships to Disclose
 
Taiichi Kawamura
No Relationships to Disclose
 
Yusuke Koseki
No Relationships to Disclose
 
Raito Asaoka
No Relationships to Disclose
 
Kenichi Nakamura
No Relationships to Disclose
 
Yuhei Waki
No Relationships to Disclose
 
Tomoyuki Irino
No Relationships to Disclose
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst)